EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Histone Modifications in Alzheimer’s Disease

Dalileia Aparecida Santana iD, Marilia de Arruda Cardoso Smith iD, Elizabeth Suchi Chen iD

Genes · 29.01.2023 · 14 (2) · 347

DOI: 10.3390/genes14020347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 29.01.2023. Verfasst von Dalileia Aparecida Santana und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology & Genetics, Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, SP, Brazil. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since Late-onset Alzheimer’s disease (LOAD) derives from a combination of genetic variants and environmental factors, epigenetic modifications have been predicted to play a role in the etiopathology of LOAD. Along with DNA methylation, histone modifications have been proposed as the main epigenetic modifications that contribute to the pathologic mechanisms of LOAD; however, little is known about how these mechanisms contribute to the disease’s onset or progression. In this review, we highlighted the main histone modifications and their functional role, including histone acetylation, histone methylation, and histone phosphorylation, as well as changes in such histone modifications that occur in the aging process and mainly in Alzheimer’s disease (AD). Furthermore, we pointed out the main epigenetic drugs tested for AD treatment, such as those based on histone deacetylase (HDAC) inhibitors. Finally, we remarked on the perspectives around the use of such epigenetics drugs for treating AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansHistonesHistone CodeDNA MethylationEpigenesis, GeneticHistone Deacetylase Inhibitors

Stichwörter der Autor:innen

Alzheimer’s diseaseaginghistone modifications

Substanzen

HistonesHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Department of Morphology & Genetics, Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, SP, Brazil.

ORCID-Profile: Dalileia Aparecida Santana, Marilia de Arruda Cardoso Smith, Elizabeth Suchi Chen

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Santana, D. A., Smith, M. A. C., & Chen, E. S. (2023). Histone Modifications in Alzheimer’s Disease. Genes, 14(2), 347. https://doi.org/10.3390/genes14020347

Vancouver

Santana DA, Smith MAC, Chen ES. Histone Modifications in Alzheimer’s Disease. Genes. 2023;14(2):347. doi:10.3390/genes14020347

BibTeX
@article{Santana2023,
  author = {Santana, Dalileia Aparecida and Smith, Marilia de Arruda Cardoso and Chen, Elizabeth Suchi},
  title = {Histone Modifications in Alzheimer’s Disease},
  journal = {Genes},
  year = {2023},
  volume = {14},
  number = {2},
  pages = {347},
  doi = {10.3390/genes14020347}
}
Kostenlos starten →